Trial · NCT04817410
Outcomes15
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants Enrolled and Receiving Formal Addiction Treatment at Day 14 | Day 14 | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Number of Participants Enrolled and Receiving Formal Addiction Treatment at Day 30 | Day 30 | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Alcoholic Drinks Per Day | 7-days prior to enrollment to day of enrollment (baseline) | # of drinks consumed per day | MEDIAN | |
| SECONDARY | Number of Daily Drinks | 30-days | 30-days | # of drinks consumed per day | MEDIAN |
| SECONDARY | Daily Alcohol Craving Scale | up to 30 days | score on a scale | MEDIAN | |
| SECONDARY | Guidelines Regimen Information Program (GRIP) Guide at Day 14 | Day 14 | Adherence to daily oral naltrexone measured using Guidelines Regimen Information Program (GRIP) guide - GRIP guide is a self-report to assess adherence, with 6 categorical items: excellent, very good, good, fair, poor, and very poor. The maximum value is 6 and the minimum value is 1. Higher scores mean better adherence. | units on a scale | MEDIAN |
| SECONDARY | Guidelines Regimen Information Program (GRIP) Guide at Day 30 | Day 30 | Adherence to daily oral naltrexone measured using the Guidelines Regimen Information Program (GRIP) guide - GRIP guide is a self-report to assess adherence, with 6 categorical items: excellent, very good, good, fair, poor, and very poor. The maximum value is 6 and the minimum value is 1. Higher scores represent better adherence. | units on a scale | MEDIAN |
| SECONDARY | Number of Pills in Bottle at Day 14 | Day 14 | Pill count at day 14. Note: Participants did not return to clinic so pill counts were not collected. | ||
| SECONDARY | Number of Pills in Bottle at Day 30 | Day 30 | Pill counts at day 30 Note: Participants did not return to clinic so pill counts were not collected. | ||
| SECONDARY | Number of Heavy Drinking Days | up to 30 days | days | MEDIAN | |
| SECONDARY | Health Services Utilization Survey | up to 30-days | Participants indicated the number of inpatient admissions, outpatient visits and emergency department visits over the preceding 7-days at baseline, 14-days and 30-days. Comparison of total reported admissions or visits were made using the Friedman test. No admissions or visits counted as a 0 for comparing across timepoints. If no response was provided at any of the three time points, the participant data was not used in the comparison. | number of occurrences | MEDIAN |
| SECONDARY | Number of Unhealthy Days Assessed by Health Related Quality of Life (HRQoL) | Day 30 | Self-reported general health was collected on a 5-item scale ranging from: excellent, very good, good, fair, and poor. An unhealthy days score was obtained by summing the number of physically unhealthy and mentally unhealthy days. The minimum score is 0 and the maximum score is 30 unhealthy days. | unhealthy days | MEDIAN |
| SECONDARY | The Patient Rated Inventory of Side Effects (PRISE) Survey | Day 30 | participants | NUMBER | |
| SECONDARY | AUD Program Satisfaction Survey at Baseline | Baseline | Three elements of satisfaction were assessed: 1) convenience of screening, 2) difficulty of screening and 3) satisfaction with screening. Each question could be scored on scale of 0-6. For convenience of screening, lower numbers indicated more convenience. For difficulty of screening, lower numbers represent less difficulty. For satisfaction, higher numbers represent greater satisfaction. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants Who Transition to LA Injectable | Day 30 | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04817410/outcomes